AKARI Therapeutics
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) (NCT05061771) | AKARI Therapeutics | 2022-05-06 |
| Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy (NCT04784455) | AKARI Therapeutics | 2021-02-01 |
| Topical rVA576 for Treatment of Atopic Keratoconjunctivitis (NCT04037891) | AKARI Therapeutics | 2019-03-04 |
| rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects (NCT04035733) | AKARI Therapeutics | 2018-09-25 |
| Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 (NCT03588026) | AKARI Therapeutics | 2018-06-07 |
| Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms (NCT03427060) | AKARI Therapeutics | 2018-05-14 |
Track AKARI Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.